Literature DB >> 1864353

Application of a new ventilator-multi-plethysmograph system for testing efficacy of surfactant replacement in newborn rabbits.

B Sun1, T Kobayashi, T Cursted, G Grossmann, B Robertson.   

Abstract

We applied a new ventilator-multi-plethysmograph system to evaluate the effect of surfactant replacement in newborn rabbits under well controlled, nearly physiological conditions characterized by normal ECG and adequate PCO2 in right ventricular heart blood obtained at the end of the experiment. Up to 10 animals were ventilated in parallel with a pressure-constant common respirator system. Using a working pressure of 4.9 kPa (50 cmH2O), we could adjust the pressure delivered to each animal within the range of 0.49-4.4 kPa (5-45 cmH2O), by changing the length of an open high-resistance tube constituting the outflow limb of the connection between the common ventilator tube and the tracheal cannula. Immature newborn animals obtained after 27.5 days gestation and ventilated for 30 min with a tidal volume of 8-10 ml.kg-1 had a mean +/- SD lung-thorax compliance of 4.2 +/- 1.1 ml.kPa-1.kg-1 (0.41 +/- 0.11 ml.cmH2O-1.kg-1) and PCO2 of 8.5 +/- 1.9 kPa. In littermates treated at birth with a large dose of natural surfactant (Curosurf, 200 mg.kg-1, compliance increased to 6.0 +/- 1.0 ml.kPa-1.kg-1 (0.68 +/- 0.10 ml.cmH2O-1.kg-1) (p less than 0.01) and PCO2 decreased to 6.9 +/- 1.2 kPa (p less than 0.01). Near-term animals, obtained at 30 days gestation and ventilated under similar conditions had a compliance of 7.2 +/- 0.9 ml.kPa-1.kg-1 (0.71 +/- 0.09 ml.cmH2O-1.kg-1) and PCO2 of 6.4 (1.2) kPa. Administration of surfactant (same dose as above) to these mature animals at birth had no adverse effects.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864353

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

Review 1.  Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.

Authors:  L R Wiseman; H M Bryson
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

Review 2.  Surfactant replacement therapy.

Authors:  M J Kresch; W H Lin; R S Thrall
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

3.  Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits.

Authors:  J D Corcoran; P Berggren; B Sun; H L Halliday; B Robertson; T Curstedt
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-11       Impact factor: 5.747

4.  Surfactant improves lung function and mitigates bacterial growth in immature ventilated rabbits with experimentally induced neonatal group B streptococcal pneumonia.

Authors:  E Herting; B Sun; C Jarstrand; T Curstedt; B Robertson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-01       Impact factor: 5.747

5.  Efficacy of synthetic surfactant (CHF5633) bolus and/or lavage in meconium-induced lung injury in ventilated newborn rabbits.

Authors:  Yaling Xu; Xiaojing Guo; Meimei Chen; Francesca Ricci; Fabrizio Salomone; Xabier Murgia; Bo Sun
Journal:  Pediatr Res       Date:  2022-06-14       Impact factor: 3.756

6.  Lipid peroxidation of lung surfactant in experimental neonatal group B streptococcal pneumonia.

Authors:  R K L Bouhafs; C Jarstrand; B Robertson
Journal:  Lung       Date:  2004       Impact factor: 2.584

7.  Suppression of pulmonary group B streptococcal proliferation and translocation by surfactants in ventilated near-term newborn rabbits.

Authors:  Yaling Xu; Ying Dong; Xiaojing Guo; Bo Sun
Journal:  Pediatr Res       Date:  2019-05-13       Impact factor: 3.756

8.  In vitro characterization and in vivo comparison of the pulmonary outcomes of Poractant alfa and Calsurf in ventilated preterm rabbits.

Authors:  Xiaojing Guo; Siwei Luo; Davide Amidani; Claudio Rivetti; Giuseppe Pieraccini; Barbara Pioselli; Silvia Catinella; Xabi Murgia; Fabrizio Salomone; Yaling Xu; Ying Dong; Bo Sun
Journal:  PLoS One       Date:  2020-03-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.